Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Aspa

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
BMC Pulmonary Medicine|December 16, 2014
The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markersOlga Rajas, Mara Ortega-Gómez, José María Galván Román, et al.
The Journal of Infection|August 11, 2016
Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcomeRosario Menéndez, Beatriz Montull, Soledad Reyes, et al.
Plos One|February 23, 2019
Correction: Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratioJose Curbelo, Sergio Luquero Bueno, José María Galván-Román, et al.
Respirology (Carlton, Vic.)|July 16, 2016
Age-related risk factors for bacterial aetiology in community-acquired pneumoniaJosé M Sahuquillo-Arce, Rosario Menéndez, Raúl Méndez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patientsRosario Menéndez, Antoni Torres, Felipe Rodríguez de Castro, et al.
Plos One|March 17, 2017
Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratioJose Curbelo, Sergio Luquero Bueno, José María Galván-Román, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2005
Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcomeRosario Menéndez, Antoni Torres, Rafael Zalacaín, et al.
Clinical Immunology (Orlando, Fla.)|June 2, 2024
Imbalance of SARS-CoV-2-specific CCR6+ and CXCR3+ CD4+ T cells and IFN-γ + CD8+ T cells in patients with Long-COVIDPedro Martínez-Fleta, María Celeste Marcos, Daniel Jimenez-Carretero, et al.
The European Respiratory Journal|April 24, 2012
The role of mannose-binding lectin in pneumococcal infectionM Isabel García-Laorden, Felipe Rodríguez de Castro, Jordi Solé-Violán, et al.
Critical Care Medicine|February 15, 2011
The Fcγ receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumoniaJordi Solé-Violán, M Isabel García-Laorden, José Alberto Marcos-Ramos, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
BMC Pulmonary Medicine|December 16, 2014
The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markersOlga Rajas, Mara Ortega-Gómez, José María Galván Román, et al.
The Journal of Infection|August 11, 2016
Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcomeRosario Menéndez, Beatriz Montull, Soledad Reyes, et al.
Plos One|February 23, 2019
Correction: Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratioJose Curbelo, Sergio Luquero Bueno, José María Galván-Román, et al.
Respirology (Carlton, Vic.)|July 16, 2016
Age-related risk factors for bacterial aetiology in community-acquired pneumoniaJosé M Sahuquillo-Arce, Rosario Menéndez, Raúl Méndez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patientsRosario Menéndez, Antoni Torres, Felipe Rodríguez de Castro, et al.
Plos One|March 17, 2017
Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratioJose Curbelo, Sergio Luquero Bueno, José María Galván-Román, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2005
Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcomeRosario Menéndez, Antoni Torres, Rafael Zalacaín, et al.
Clinical Immunology (Orlando, Fla.)|June 2, 2024
Imbalance of SARS-CoV-2-specific CCR6+ and CXCR3+ CD4+ T cells and IFN-γ + CD8+ T cells in patients with Long-COVIDPedro Martínez-Fleta, María Celeste Marcos, Daniel Jimenez-Carretero, et al.
The European Respiratory Journal|April 24, 2012
The role of mannose-binding lectin in pneumococcal infectionM Isabel García-Laorden, Felipe Rodríguez de Castro, Jordi Solé-Violán, et al.
Critical Care Medicine|February 15, 2011
The Fcγ receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumoniaJordi Solé-Violán, M Isabel García-Laorden, José Alberto Marcos-Ramos, et al.
Pageof 4